Experts discussed the latest advances in CLL clinical trials highlighted at the 2021 American Society of Hematology (ASH) meeting, the world’s premier conference in hematology.
Dr. Michael Keating, Founder, CLL Global Research Foundation
Dr. William Wierda, President & CEO, CLL Global Research Foundation
Dr. Alessandra Ferrajoli, Associate Medical Director, Department of Leukemia, MD Anderson Cancer Center
Jeff Folloder, Moderator and CLL patient advocate
William Wierda, President and CEO, discusses the ways in which the CLL Global Research Foundation is different and how the organization’s collaborative spirit advances CLL research.
CLL researchers, Dr. Jennifer Woyach and Dr. Deep Sampath, discuss how they work together and their currently funded CLL Global Research Foundation project.
CLL Global Research Foundation’s Chairman of the Board, Steve Winfield, discusses the power of the organization and how donations are used to advance CLL research and treatments.
Dr. Carlo Croce discusses the history of CLL research, his connection to the CLL Global Research Foundation, and how the organization has impacted advancements in the field.
William Wierda, President and CEO of the CLL Global Research Foundation discusses his hope for the future of the organization.
Dr. George Calin discusses his current research projects that are funded by the CLL Global Research Foundation and shares how the organization has impacted the field of CLL over the years.
